CRM vs IBM
CRM and IBM side by side — valuation & fundamentals (public data).
Key statistics
| Metric | CRMSalesforce, Inc. | IBMINTERNATIONAL BUSINESS MACHINES CORPORATION |
|---|---|---|
| Market cap | $157.63B | $223.34B |
| P/E (TTM) | 22.3 | 21.0 |
| P/B | 4.60 | 6.48 |
| P/S | 3.8x | 3.3x |
| Dividend yield | 1.01% | 2.80% |
| Revenue | $42.83B(TTM) | $69.09B(TTM) |
| Revenue growth (YoY) | 9.6% | 7.6% |
| Net income | $8.02B(TTM) | $10.72B(TTM) |
| Earnings growth (YoY) | 20.3% | 75.9% |
| EPS, diluted | $8.63(TTM) | $11.29(TTM) |
| EBIT margin | 20.1% | 18.2% |
| ROE | 21.8% | 30.7% |
| ROIC | 10.1% | 13.1% |
| Piotroski F | 7/9 | 7/9 |
| 1y total return | -19.3% | -2.5% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: CRM frente a IBM
| Métrica | CRM | IBM |
|---|---|---|
| Valor final | $25.9K | $24.2K |
| Retorno total | +159.1% | +142.3% |
| CAGR | +9.7% | +8.9% |
| Volatilidad | 35.3% | 28.0% |
| Sharpe | 0.33 | 0.31 |
| Sortino | 0.47 | 0.42 |
| Caída máxima | -58.7% | -40.6% |
Basado en 2600 días de negociación comunes, 2016-04-06 → 2026-08-07 · tasa libre de riesgo 3.9% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)